Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 103 are a BUY (92.79%), 8 are a HOLD (7.21%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 54.7% that have a potential upside of 35.49% achieved within 90 days.
Marie Thibault’s has documented 223 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NARI, Inari Medical at 08-Jan-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$158
$30.07 (23.51%)
$149
5 days ago
(27-Jan-2025)
16/25 (64%)
$28.57 (22.07%)
385
Buy
$148
$20.07 (15.69%)
$146
9 days ago
(23-Jan-2025)
8/13 (61.54%)
$30.22 (25.66%)
256
Buy
$135
$7.07 (5.53%)
$115
9 days ago
(23-Jan-2025)
13/14 (92.86%)
$17.22 (14.62%)
313
Hold
$130
$2.07 (1.62%)
$105
3 months 15 days ago
(17-Oct-2024)
4/5 (80%)
$12.11 (10.27%)
124
Hold
$125
$-2.93 (-2.29%)
$112
3 months 15 days ago
(17-Oct-2024)
11/12 (91.67%)
$7.11 (6.03%)
289
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?